MRD / Regn No. : THBC\23-24\02845 Date : 10/06/2026
Patient Name : Farida Naglekar Age & Gender : 72 Yrs. / Female
Contact No. : 9819686712 UHID :
Ht / Wt / BMI : BP S / BP D :
Allergies : NONE Referred By :
   
Problem List : T2DM (06/Jan/2016) | HYPOTHYROIDISM (03/Jan/2006) |
Subjective : T2DM SINCE 8 YRS,HYPOTHYROIDISM SINCE 21 YEARS,LAST HBA1C 6.6%,MOBILITY BETTER AFTER PARTIAL KNEE REPLACEMENT IN DEC 25,XRAY SPINE - ANT WEDGING OF SPINE - SEVERE OSTEOPOROSIS,DO NOT STOP DENOSUMAB WITHOUT CONSULTING ME
Objective : 25-MAY-2026 REPORTS,HBA1C-8.3%,TSH-0.491,HOME CHECK FBS 133 / PPBS 192 MG/DL
Plan : ADDING DIAMICRON XR MEX 30/500 MG - CHECK FBS / PPBS AND TEXT ME  
S# Generic (Trade) Name Route Dosage Usage Duration
1 WALIGO M (50+500) ORAL 1-0-1 ABF / AD
4 MTHS
2 ATORLIP F ORAL 0-0-1 AD
4 MTHS
3 ABMETOP 25 ORAL 1-0-0 ABF
4 MTHS
4 TELIONE CH ORAL 0-0-1 AD
4 MTHS
5 TABLET CHOLECALCIFEROL
DRISE 60,000
ORAL 1/MONTH ANYTIME OF DAY
4 MTHS
6 PREGEB M OD 75 MG ORAL 0-0-1/2-0 EVENING 7 PM
4 MTHS
7 LOTUSCAL PLUS ORAL 0-1-0 AL / 3 DAYS A WEEK
4 MTHS
8 TAB THYRONORM 125 MCG SC 1-0-0 BBF / 6 DAYS A WEEK
4 MNTHS
9 DENOSUMAB 60 MCG SC 1/6 MTHS
TO CONTINUE
10 TABLET GLICLAZIDE (30MG) AND METFORMIN (500MG)
DIAMICRON XR MEX 30+500 MG
ORAL 1-0-0 BEFORE BREAKFAST
4 MTHS
       
Refill : 0 / Substitution:    
Education :
Next Visit : 26/Sep/2026
Tests Suggested For Next Visit : FBS / PPBS / HBA1C /TSH > 4 MTHS
   
   

Dr Tejal Lathia
M.D, D.M (Endocrinology)
Maharashtra / 2003/05/2166

This is a Computer generated Prescription

Powered By: